Novonesis B is a publicly traded company trading on OTC, led by CEO Ester Baiget.
No upcoming earnings scheduled for Novonesis B
No earnings announcement scheduled
Past 12 earnings reports for Novonesis B
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | FY 2025 | $1.73 | — | $4.2BEst: $4.9B | -15.1% | — |
| Aug 21, 2025 | H1 2025 | $0.88 | — | $2.4B | — | — |
| Feb 26, 2025 | FY 2024 | $1.39 | — | $4.1B | — | — |
| Aug 27, 2024 | H1 2024 | $0.69 | — | $2.1B | — | — |
| Feb 1, 2024 | Q4 2023 | $0.36Est: $0.44 | -18.2% | $664.2MEst: $674.7M | -1.6% | — |
| Oct 26, 2023 | Q3 2023 | $0.49Est: $0.42 | +16.7% | $650.5MEst: $634.3M | +2.6% | — |
| Aug 9, 2023 | Q2 2023 | $0.32Est: $0.42 | -23.8% | $616.5MEst: $632.0M | -2.5% | — |
| Apr 26, 2023 | Q1 2023 | $0.41Est: $0.44 | -6.8% | $666.3MEst: $662.6M | +0.6% | — |
| Jan 26, 2023 | Q4 2022 | $0.43Est: $0.41 | +4.9% | $606.1MEst: $671.9M | -9.8% | — |
| Nov 3, 2022 | Q3 2022 | $0.56Est: $0.62 | -9.7% | $591.7MEst: $622.4M | -4.9% | — |
| Aug 11, 2022 | Q2 2022 | $0.42 | — | $614.0M | — | — |
| Apr 27, 2022 | Q1 2022 | $0.45 | — | $659.4M | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.